What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Could GraftAssureDx reshape access to transplant rejection monitoring? (Nasdaq: IMDX) Could GraftAssureDx decentralize transplant rejection monitoring? Learn what Insight Molecular Diagnostics Inc.’s FDA push means for transplant diagnostics. bySoujanya RaviMarch 6, 2026